Last reviewed · How we verify
JE vaccine new plant lot 1
JE vaccine new plant lot 1 is a vaccine Biologic drug developed by International Centre for Diarrhoeal Disease Research, Bangladesh. It is currently FDA-approved for Prevention of Japanese encephalitis in endemic regions.
JE vaccine stimulates the immune system to produce antibodies and cellular immunity against Japanese encephalitis virus.
JE vaccine stimulates the immune system to produce antibodies and cellular immunity against Japanese encephalitis virus. Used for Prevention of Japanese encephalitis in endemic regions.
At a glance
| Generic name | JE vaccine new plant lot 1 |
|---|---|
| Sponsor | International Centre for Diarrhoeal Disease Research, Bangladesh |
| Drug class | vaccine |
| Target | Japanese encephalitis virus envelope proteins |
| Modality | Biologic |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Mechanism of action
The vaccine contains inactivated Japanese encephalitis virus antigen that triggers both humoral (antibody) and cell-mediated immune responses. This primes the immune system to recognize and neutralize the virus upon natural exposure, preventing infection or reducing disease severity. The plant-derived formulation represents a production method using plant-based expression systems rather than traditional cell culture or animal-derived sources.
Approved indications
- Prevention of Japanese encephalitis in endemic regions
Common side effects
- Local injection site reactions (pain, erythema, swelling)
- Fever
- Myalgia
- Headache
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- JE vaccine new plant lot 1 CI brief — competitive landscape report
- JE vaccine new plant lot 1 updates RSS · CI watch RSS
- International Centre for Diarrhoeal Disease Research, Bangladesh portfolio CI
Frequently asked questions about JE vaccine new plant lot 1
What is JE vaccine new plant lot 1?
How does JE vaccine new plant lot 1 work?
What is JE vaccine new plant lot 1 used for?
Who makes JE vaccine new plant lot 1?
What drug class is JE vaccine new plant lot 1 in?
What development phase is JE vaccine new plant lot 1 in?
What are the side effects of JE vaccine new plant lot 1?
What does JE vaccine new plant lot 1 target?
Related
- Drug class: All vaccine drugs
- Target: All drugs targeting Japanese encephalitis virus envelope proteins
- Manufacturer: International Centre for Diarrhoeal Disease Research, Bangladesh — full pipeline
- Therapeutic area: All drugs in Immunology
- Indication: Drugs for Prevention of Japanese encephalitis in endemic regions
- Compare: JE vaccine new plant lot 1 vs similar drugs
- Pricing: JE vaccine new plant lot 1 cost, discount & access